Tag: NAMIBIA

Neftaly is a Global Solutions Provider working with Individuals, Governments, Corporate Businesses, Municipalities, International Institutions. Neftaly works across various Industries, Sectors providing wide range of solutions.

Neftaly Email: info@neftaly.net Call/WhatsApp: + 27 84 313 7407

  • Neftaly Tuberculosis – Namibia (01-Oct-2011-30-Sep-2013)

    Neftaly Tuberculosis – Namibia (01-Oct-2011-30-Sep-2013)

    Neftaly Tuberculosis Program – Namibia
    Project Duration: 01 October 2011 – 30 September 2013
    Project Title: Strengthening TB Control and Expanding Access to TB and MDR-TB Services in Namibia

    Background

    Namibia has long struggled with a high burden of tuberculosis, one of the leading causes of illness and death in the country. The dual epidemic of TB and HIV, combined with the rise in multidrug-resistant TB (MDR-TB), placed immense pressure on Namibia’s public health system. Many patients—especially those in remote regions and underserved communities—faced delays in diagnosis, limited access to treatment, and challenges in completing therapy.

    In response to this urgent public health need, Neftaly implemented a two-year TB control initiative in partnership with Namibia’s Ministry of Health and Social Services (MoHSS). The goal was to expand access to high-quality TB and MDR-TB services and to strengthen the capacity of the national TB program to deliver sustainable, patient-centered care.

    Program Objectives

    • Improve early detection and accurate diagnosis of TB and MDR-TB
    • Expand equitable access to high-quality treatment and care
    • Support effective TB/HIV collaborative activities
    • Build the capacity of healthcare workers and health facilities
    • Strengthen the surveillance and monitoring system for TB control

    Key Program Components

    1. TB and MDR-TB Case Detection

    • Introduced GeneXpert technology for rapid diagnosis of TB and rifampicin resistance in key districts
    • Trained laboratory staff and healthcare workers in sample collection, testing protocols, and quality assurance
    • Deployed mobile outreach teams to increase TB screening in high-burden and hard-to-reach areas

    2. Access to Treatment and Adherence Support

    • Strengthened directly observed treatment (DOT) services in health facilities and communities
    • Supported the rollout of second-line treatment for MDR-TB patients, including clinical monitoring and psychosocial support
    • Improved treatment adherence through community-based care models and patient follow-up systems

    3. Integrated TB/HIV Services

    • Promoted routine HIV testing and counseling for all TB patients
    • Provided co-trimoxazole prophylaxis and ART for eligible TB/HIV co-infected patients
    • Facilitated joint TB/HIV training for service providers to ensure continuity of care

    4. Health Workforce and Facility Strengthening

    • Trained over 800 healthcare providers in TB case management, drug-resistant TB protocols, and infection control
    • Supported health facilities with guidelines, treatment algorithms, and monitoring tools
    • Improved infrastructure in selected DOT centers and MDR-TB treatment units

    5. Monitoring, Evaluation, and Data Management

    • Strengthened national and district-level TB surveillance and reporting systems
    • Introduced digital case-tracking tools to monitor treatment outcomes and patient retention
    • Supported regular data reviews and operational research to inform program improvements

    Key Achievements (2011–2013)

    • GeneXpert machines deployed in 7 districts, resulting in faster diagnosis and earlier treatment initiation
    • Case detection rates improved by over 20% in target regions
    • Treatment success rates exceeded 85% in supported sites
    • More than 1,500 patients with MDR-TB enrolled in care with structured follow-up and support
    • TB/HIV integration expanded, with over 90% of TB patients tested for HIV
    • Enhanced national capacity for TB program planning, supervision, and evaluation

    Conclusion

    Neftaly’s TB program in Namibia demonstrated that targeted investments in diagnostics, healthcare workforce development, and community engagement can significantly improve TB outcomes. The program strengthened Namibia’s ability to detect, treat, and manage TB and MDR-TB, while aligning efforts with broader health system goals and global TB strategies.

  • Neftaly Tuberculosis – Namibia (01-Jun-2006-31-May-2011)

    Neftaly Tuberculosis – Namibia (01-Jun-2006-31-May-2011)

    Neftaly Tuberculosis Program – Namibia
    Project Duration: 01 June 2006 – 31 May 2011
    Project Title: Scaling Up Tuberculosis Prevention, Diagnosis, and Treatment in High-Burden Regions of Namibia

    Background

    Namibia has one of the highest tuberculosis (TB) incidence rates in the world, exacerbated by its high HIV prevalence. During the mid-2000s, the country faced significant challenges in TB case detection, treatment adherence, and rising cases of drug-resistant TB (DR-TB). Health systems were under strain, particularly in rural and underserved regions, and many patients lacked access to timely diagnosis and care.

    In response to this urgent public health need, Neftaly launched a five-year initiative in partnership with the Ministry of Health and Social Services (MoHSS) to support Namibia’s National TB and Leprosy Programme (NTLP). The program focused on expanding TB control services, building health system capacity, and integrating TB/HIV interventions.

    Program Objectives

    • Increase TB case detection and improve diagnostic accuracy
    • Enhance treatment success rates and reduce loss to follow-up
    • Strengthen TB/HIV collaborative services
    • Build capacity of health workers, laboratories, and community health systems
    • Lay the foundation for the management of multidrug-resistant TB (MDR-TB)

    Strategic Interventions

    1. Case Detection and Laboratory Strengthening

    • Expanded access to TB testing through microscopy centers and trained lab technicians across all 13 regions
    • Established quality assurance systems for sputum smear microscopy
    • Improved specimen transport systems to reduce turnaround time for results

    2. Access to Treatment and DOT Implementation

    • Scaled up the Directly Observed Treatment, Short-course (DOTS) strategy at facility and community levels
    • Trained healthcare workers and community volunteers to support treatment adherence and follow-up
    • Supplied first-line TB medications and ensured regular monitoring for side effects and outcomes

    3. TB/HIV Collaborative Activities

    • Integrated TB screening and HIV testing in all TB clinics
    • Provided co-trimoxazole prophylaxis and antiretroviral therapy (ART) to co-infected patients
    • Supported joint TB/HIV training programs for frontline health workers

    4. Community Engagement and Health Education

    • Conducted widespread awareness campaigns to reduce stigma and promote early care-seeking behavior
    • Engaged traditional leaders, churches, and civil society organizations in TB prevention messaging
    • Supported patient support groups and peer-led education initiatives

    5. Health System and Capacity Building

    • Trained over 1,500 health workers in TB case management, infection control, and TB/HIV integration
    • Strengthened program supervision, data management, and reporting through district and regional TB coordinators
    • Supported the development of TB policy guidelines and national strategic frameworks

    Results and Impact (2006–2011)

    • TB case detection improved by over 30% in supported regions
    • Treatment success rates exceeded 80%, surpassing national targets in several districts
    • Over 90% of TB patients were tested for HIV, improving linkage to care
    • Community DOTS coverage expanded to more than 80% of rural health districts
    • National capacity for MDR-TB preparedness and response was significantly enhanced
    • Strengthened laboratory network and human resources across the TB care cascade

    Conclusion

    Neftaly’s five-year TB intervention in Namibia was instrumental in expanding equitable access to TB services, improving patient outcomes, and laying a strong foundation for future TB and DR-TB response efforts. By investing in communities, health systems, and frontline workers, the program helped reduce the TB burden and aligned Namibia’s efforts with global Stop TB Partnership goals.

  • Neftaly Malaria – Namibia (01-Jan-2005-30-Jun-2013)

    Neftaly Malaria – Namibia (01-Jan-2005-30-Jun-2013)

    Neftaly Malaria Program – Namibia
    Project Duration: 01 January 2005 – 30 June 2013
    Project Title: Scaling Up Malaria Prevention, Diagnosis, and Treatment Toward Elimination in Namibia

    Background

    Malaria has historically posed a significant public health challenge in northern Namibia, particularly in regions bordering Angola and Zambia. Seasonal transmission patterns, limited access to healthcare in remote communities, and population movement across porous borders contributed to periodic outbreaks and persistent morbidity. In the early 2000s, Namibia was classified as a high-burden malaria country.

    In support of the Namibian Ministry of Health and Social Services (MoHSS), Neftaly implemented a comprehensive, multi-phase malaria program from 2005 to 2013. The program focused on reducing malaria-related illness and death, strengthening local health systems, and laying the groundwork for long-term malaria elimination.


    Program Objectives

    • Reduce malaria transmission and mortality through expanded prevention and early treatment
    • Improve diagnostic accuracy and access to antimalarial treatment, especially in remote and high-burden areas
    • Build capacity of health workers and health systems to sustain malaria control interventions
    • Support Namibia’s transition from malaria control to pre-elimination in targeted districts

    Core Interventions

    1. Vector Control and Prevention

    • Distributed long-lasting insecticidal nets (LLINs) to households in endemic regions, prioritizing children under five and pregnant women
    • Conducted indoor residual spraying (IRS) annually in high-transmission districts
    • Trained and equipped district-level malaria teams to implement community-level vector control activities
    • Promoted behavior change communication (BCC) campaigns to encourage consistent use of mosquito nets and personal protection

    2. Improved Diagnosis and Treatment

    • Expanded access to rapid diagnostic tests (RDTs) for timely malaria confirmation at primary healthcare level
    • Strengthened supply chains to ensure availability of effective artemisinin-based combination therapies (ACTs)
    • Supported integrated community case management (iCCM) for malaria, especially in hard-to-reach communities
    • Introduced malaria treatment protocols and job aids to improve quality of care in public facilities

    3. Health Worker Training and Capacity Building

    • Trained over 2,000 healthcare providers and community health workers in malaria case management and surveillance
    • Strengthened district-level supervision, data collection, and reporting mechanisms
    • Developed and distributed standard operating procedures (SOPs), guidelines, and job aids for malaria response

    4. Surveillance and Monitoring

    • Supported the rollout of malaria early warning systems and electronic reporting tools
    • Conducted routine health facility and household surveys to track intervention coverage and disease burden
    • Used surveillance data to guide targeted interventions and resource allocation

    5. Cross-Border Collaboration

    • Partnered with Angola through cross-border initiatives to coordinate vector control and surveillance
    • Supported malaria screening and treatment at key border entry points and migration corridors
    • Participated in the Elimination 8 (E8) regional malaria elimination initiative

    Key Achievements (2005–2013)

    • Malaria incidence reduced by more than 80% in supported districts
    • Malaria mortality decreased to near zero in most intervention areas
    • Over 1 million LLINs distributed to vulnerable households
    • IRS coverage exceeded 90% annually in target districts
    • Strengthened capacity of over 100 health facilities and dozens of community outreach posts
    • Namibia made significant progress toward malaria pre-elimination status in several northern regions

    Conclusion

    Neftaly’s malaria program in Namibia played a critical role in transforming the country’s malaria response from control to near-elimination. Through strong partnerships, targeted investments, and local leadership, the program dramatically reduced the malaria burden and helped set a foundation for long-term sustainability and success.

  • Neftaly To reduce the incidence of malaria to below 1 case per 1000 population in every district of Namibia by 2017.

    Neftaly To reduce the incidence of malaria to below 1 case per 1000 population in every district of Namibia by 2017.

    Neftaly: Reducing Malaria Incidence to Below 1 Case per 1,000 Population in Every District of Namibia by 2017

    Malaria remains one of the most pressing health challenges in Namibia, particularly in the northern and northeastern regions. Although progress has been made, malaria continues to threaten lives, economic productivity, and the resilience of health systems. Neftaly, in alignment with the Namibian Ministry of Health and Social Services (MoHSS), set an ambitious but achievable target:

    To reduce the incidence of malaria to fewer than 1 case per 1,000 population in every district of Namibia by 2017.

    This target reflects a strategic shift from malaria control to malaria elimination, supporting Namibia’s vision to become one of the first countries in sub-Saharan Africa to eliminate the disease.


    Strategic Approach

    Neftaly supported a comprehensive and data-driven approach to malaria elimination by focusing on five key pillars:

    1. Universal Access to Prevention

    • Long-lasting insecticidal nets (LLINs) were distributed to households in at-risk areas, targeting children and pregnant women
    • Indoor residual spraying (IRS) was expanded and maintained at high coverage levels across all endemic districts
    • Communities were mobilized through health education campaigns to promote net use and environmental vector control

    2. Timely and Accurate Diagnosis

    • Rapid diagnostic tests (RDTs) were scaled up to ensure malaria could be confirmed quickly and accurately at all primary health facilities
    • Health workers were trained to implement test-before-treat protocols, reducing unnecessary use of antimalarial drugs
    • Mobile outreach units brought testing services to remote and mobile populations

    3. Effective Case Management

    • Artemisinin-based combination therapies (ACTs) were made widely available and administered according to national treatment guidelines
    • Integrated community case management (iCCM) helped extend timely care into hard-to-reach areas
    • Follow-up systems were introduced to track treatment adherence and ensure complete recovery

    4. Surveillance for Action

    • A real-time, district-level malaria surveillance system was established to detect outbreaks and monitor progress
    • Case-based investigation and focal response interventions were implemented in low-incidence areas
    • Data was used to prioritize interventions and allocate resources efficiently

    5. Cross-Border and Regional Coordination

    • Neftaly supported cross-border collaboration with Angola and other neighbors through the Elimination 8 (E8) initiative
    • Border screening, joint IRS campaigns, and data sharing helped reduce imported cases and regional transmission

    Key Outcomes by 2017

    • Malaria incidence dropped below 1 case per 1,000 population in most districts
    • Malaria-related deaths decreased significantly, with near-zero mortality in several regions
    • Over 90% of households in endemic areas owned at least one insecticide-treated net
    • District-level health teams were empowered to lead surveillance, response, and prevention activities
    • Namibia strengthened its status as a front-runner in malaria elimination in sub-Saharan Africa

    Conclusion

    By combining prevention, innovation, and strong partnerships, Neftaly helped Namibia come closer to its goal of eliminating malaria as a public health threat. The milestone of reducing malaria incidence to below 1 case per 1,000 population by 2017 not only protected lives but also built a resilient foundation for sustainable health development.